)
India's seafood exports reached a record high in FY26, with growth in China, EU and Southeast Asia helping offset a decline in shipments to the US due to higher tariffs
The US has initiated the process of refunding reciprocal tariffs from April 20, and Indian exporters should proactively engage with American buyers to seek a share of the refunded duties, think tank GTRI said on Tuesday. The Global Trade Research Initiative (GTRI) said that the engagement will be important as the refunded payments go only to US importers, and exporters have no legal right to claim them. Indian exporters will have no direct legal route to claim refunds, it said. The US tariffs, imposed from April 2, 2025, affected export of many Indian products, it said, adding that the total refund is about USD 166 billion, with roughly USD 12 billion linked to goods from India. To get refunds, US importers must file detailed claims online with shipment data, tariff lines and proof of payment. The reciprocal tariff regime began at 10 per cent on April 2, 2025 and was rapidly escalated. Rates for India rose to 25 per cent by Aug. 7, 2025 and to 50 per cent by August 28, remaining a
A refund system for businesses that paid tariffs which the US Supreme Court ruled President Donald Trump imposed without the constitutional authority to do so is scheduled to launch Monday. Importers and their brokers will be able to begin claiming refunds through an online portal beginning at 8 am, according to US Customs and Border Protection (CBP), the agency administering the system. It is the first step in a complicated process that also might eventually lead to refunds for consumers who were billed for some or all of the tariffs on products shipped to them from outside the United States. Companies must submit declarations listing the goods on which they collectively put billions of dollars toward the import taxes the court subsequently struck down. If CBP approves a claim, it will take 60-90 days for a refund to be issued, the agency said. The government expects to process refunds in phases, however, focusing first on more recent tariff payments. Any number of technical facto
Trump is seeking to restore his tariff wall using different authorities after the high court ruled that his use of emergency powers to impose those earlier duties was unconstitutional
The centerpiece of US President Donald Trump's economic policy sweeping taxes on global imports is under legal assault again. The US Court of International Trade, a specialised court in New York, heard oral arguments on Friday in an attempt to overturn the temporary tariffs Trump turned to after the Supreme Court in February struck down his preferred choice even bigger, even more sweeping tariffs. In his first attempt to impose global tariffs, the president last year invoked the 1977 International Emergency Economic Powers Act (IEEPA), using the law to declare America's longstanding trade deficit a national emergency and to impose double-digit worldwide taxes on imports to combat it. He interpreted the law broadly to justify tariffs of whatever size he wanted, whenever he wanted to impose them, on whatever country he wanted to target. The Supreme Court struck those tariffs down on February 20, saying IEEPA did not authorise the use of tariffs to counter national emergencies. Bu
The latest bilateral engagement is a product of necessity amid the ongoing global turbulence, not trust
Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here's the investment strategy.
Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated
US tariffs on patented drugs may have limited immediate impact on India, but industry flags uncertainty as policy ties relief to pricing and manufacturing shifts
The US plans tariffs of up to 100 per cent on imported medicines to reduce foreign dependence and boost domestic manufacturing, a move that could reshape global pharmaceutical supply chains
The US has announced a 100 per cent tariff on patented pharma imports from countries like India without reshoring deals, aiming to boost local production, while generics have been exempted for now
Duties for products made by certain larger companies will take effect in 120 days, while items from smaller manufacturers won't be hit for another 180 days, according to a White House statement
A year after it was announced, 'Liberation Day' has altered the mechanics of global trade as tariffs have succeeded in forcing negotiations in some cases and reshaping supply chains in others
The Nifty Metal index fell over 3 per cent to hit an intraday low of 11,052.55, dragged by Hindustan Copper, Hindustan Zinc, APL Apollo Tubes, Tata Steel, SAIL, Adani Enterprises, and Jindal Steel
US plans 50% tariffs on many derivative goods, based on import value while others will face 25% duties, with some products taxed at even lower rates
Talks on the e-commerce import duty ban reached a deadlock between Brazil and the US
The conclusion of negotiations for the agreement was announced by Australian PM Anthony Albanese and Ursula von der Leyen, the EU's top executive
The unusually rapid pace of these 76 inquiries raises concerns over due process, with expectations that responses may align closely with the Trump administration's preferred outcomes
The production-linked incentive scheme for large-scale electronics manufacturing, due to end on March 31, has propelled India as the second-largest smartphone maker in the world. What's its future?